Flagship explainer

How Silence Therapeutics plc makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$559000 · 100%Cost of revenue$215000 · 38%Gross profit$344000 · 62%Operating income−$91.1M · −16293%Income before tax−$88.6M · −15850%Income tax$11000 · 2%Net income−$88.6M · −15852%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$559000100%
Cost of revenue$21500038%
$34400062%
−$91.1M−16293%
Income before tax−$88.6M−15850%
Income tax$110002%
−$88.6M−15852%
Source: · event Dec 31, 2025 · retrieved Jul 26, 2026 · annual-row source set
Embed this chart

View the full Silence Therapeutics plc analysis at Buy Like Buffett